Illness	Number of cases
Hyperplasia of prostate (N40)	156
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	137
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	98
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	93
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	90
Calculus of kidney and ureter - Calculus of ureter (N20.1)	74
Cystitis (N30.0)	70
Unspecified haematuria (R31)	66
Acute tubulo-interstitial nephritis (N10)	44
Calculus of kidney and ureter - Calculus of kidney (N20.0)	37

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	609
Computer-assisted analysis of the images with 3D-analysis (3-990)	475
Computed tomography (CT) of the abdomen without contrast medium (3-207)	305
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	257
Computed tomography of the abdomen with contrast medium (3-225)	146
Insertion, exchange or removal of a ureteral stent (8-137.00)	138
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	91
Injection or administration of medicines into the urinary bladder (8-132.x)	87
(9-984.7)	73
(9-984.8)	67

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06
CQ27
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
160	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
131	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
101	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies